Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are administered 2 months apart for children aged 12–23 months, with a booster dose 12–24 months later. Our objective was to provide data on persistence of human serum bactericidal antibody (hSBA) titres i...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Sadarangani, M, Sell, T, Iro, M, Snape, M, Voysey, M, Finn, A, Heath, P, Bona, G, Esposito, S, Diez-Domingo, J, Prymula, R, Odueyungbo, A, Toneatto, D, Pollard, A
Định dạng: Journal article
Được phát hành: Canadian Medical Association 2017